Panel Discussion: The Role of Protein Biomarkers in Advancing Oncology Research

Olink, part of Thermo Fisher Scientific, together with Psomagen, is excited to invite you to an expert panel discussion exploring how protein biomarkers are reshaping the future of oncology research.

As the field moves beyond genomics and transcriptomics, protein-level insights are unlocking new opportunities to understand tumor biology, guide therapeutic strategies, and accelerate translational research. This session will bring together leaders across industry and CRO services to examine the evolving landscape, unmet needs, and the innovations enabling next-generation oncology studies.

What You’ll Learn:

• How protein biomarkers are transforming oncology research—and where the biggest unmet needs still exist across discovery and clinical development.
• The evolving role of CROs in translational proteomics, including workflow standardization, data quality, and how partnerships can accelerate multi-omics studies.
• The potential of non-invasive, protein-based liquid biopsies, along with the technical challenges and emerging AI-driven approaches that will shape future clinical adoption.

Organised in collaboration with